Preferences help
enabled [disable] Abstract
Number of results
2019 | 124 | 2 | 183-192
Article title

Gastro-oesophageal cancer related malnutrition: a challenge case to manage

Title variants
Languages of publication
Gastro-esophageal cancer is a very common malignant tumours arising from the digestive tract. Hypoalbuminemia and weight loss often result from malnourishment. Malnourished patients have a higher incidence of mortality and morbidity causing prolonged hospital stay. To discuss the incidence and effects of Gastro-esophageal cancer related malnutrition and demonstrate different methods to solve this problem. The current review revealed that malnutrition increases the risk of complications and duration of stay in hospital and ICU in GIT cancer patients, as such, accounts for burden on ICU budget.
Physical description
  • Department of Anesthesia, ICU and Pain Relief, South Egypt Cancer Institute, Assiut University, Arab Republic of Egypt
  • Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Arab Republic of Egypt
  • Department of Anesthesia and ICU, Faculty of Medicine, Minia University, Arab Republic of Egypt
  • [1] Pedrosa IV, Burgos M, Souza NC, et al. Aspectos nutricionais em obesos antes e após a cirurgia bariátrica. Rev Col Bras Cir. 2009; 36(4): 316-22
  • [2] M. I. T. D. Correia and D. L. Waitzberg, The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis, Clinical Nutrition, vol. 22, no. 3, pp. 235-239, 2003
  • [3] K. Norman, C. Pichard, H. Lochs, and M. Pirlich, Prognostic impact of disease-related malnutrition, Clinical Nutrition, vol. 27, no. 1, pp. 5-15, 2008
  • [4] D. L. Waitzberg, W. T. Caiaffa, and M. I. T. D. Correia, Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients, Nutrition, vol. 17, no. 7-8, pp. 573-580, 2001
  • [5] F. Bozzetti, L. Gianotti, M. Braga, V. Di Carlo, and L. Mariani, Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support, Clinical Nutrition, vol. 26, no. 6, pp. 698–709, 2007
  • [6] J. Sorensen, J. Kondrup, J. Prokopowicz et al., Euro OOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome, Clinical Nutrition, vol. 27, no. 3, pp. 340–349, 2011
  • [7] M. Correia, M. Cravo, P. Marques-Vidal et al., Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer, Clinical Nutrition, vol. 26, no. 6, pp. 728–735, 2009
  • [8] F. Bozzetti, M. Braga, L. Gianotti, C. Gavazzi, and L. Mariani, Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial, Lancet, vol. 358, no. 9292, pp. 1487–1492, 2011
  • [9] Y. Zheng, F. Li, B. Qi et al., Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials, Asia Pacific Journal of Clinical Nutrition, vol. 16, supplement 1, pp. 253-257, 2007
  • [10] Reeves GK, Pirie K, Beral V, et al.: Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335 (7630): 1134, 2007
  • [11] Wojtaszek CA, Kochis LM, Cunningham RS: Nutrition impact symptoms in the oncology patient. Oncology Issues 17 (2): 15-7, 2012
  • [12] Langstein HN, Norton JA: Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 5 (1): 103-23, 1991
  • [13] Ottery FD: Cancer cachexia: prevention, early diagnosis, and management. Cancer Pract 2 (2): 123-31, 1994 Mar-Apr.
  • [14] Tisdale MJ: Biology of cachexia. J Natl Cancer Inst 89 (23): 1763-73, 1997
  • [15] Gambardella A, Tortoriello R, Tagliamonte MR, et al.: Metabolic changes in elderly cancer patients after glucose ingestion. The role of tumor necrosis factor-alpha. Cancer 79 (1): 177-84, 2007
  • [16] Ottery FD: Cancer cachexia: prevention, early diagnosis, and management. Cancer Pract 2 (2): 123-31, 2009 Mar-Apr.
  • [17] Kutynec CL, McCargar L, Barr SI, et al.: Energy balance in women with breast cancer during adjuvant treatment. J Am Diet Assoc 99 (10): 1222-7, 2014
  • [18] Bosaeus I, Daneryd P, Svanberg E, et al.: Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer 93 (3): 380-3, 2011
  • [19] Murphy S, Von Roenn JH: Pharmacological management of anorexia and cachexia. In: McCallum PD, Polisena CG, eds.: The Clinical Guide to Oncology Nutrition. Chicago, Ill: The American Dietetic Association, 2015, pp. 127-33
  • [20] Kanda M, Fujii T, Kodera Y, et al. Nutritional predictors of postoperative outcome in pancreatic cancer. British Journal of Surgery 2011; 98: 268–274
  • [21] Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009; 37(5): 1649-54
  • [22] Wiedermann CJ, Wiedermann W, Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med. 2010; 36: 1657-1665
  • [23] Shitanshu U, Ahmed AN, Laurel W. Rice, et al. Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecologic Oncology 131 (2013) 416-422
  • [24] Mizock BA. Immunonutrition and critical illness: an update. Nutrition 2010; 26(7-8): 701-7
  • [25] Braga M. The Award for General Nutrition. Immunonutrition: from laboratory to clinical practice. Nutrition 2007; 23(4): 368-70
  • [26] Mongardon N, Singer M. The evolutionary role of nutrition and metabolic support in critical illness. Crit Care Clin 2010; 26(3): 443-50
  • [27] Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007; 28(4): 176-83.
  • [28] Dewar D, Moore FA, Moore EE, et al. Postinjury multiple organ failure. Injury 2009; 40(9): 912-8
  • [29] Marik PE. Critical illness related corticoseroid insufficiency. Chest 2009; 135(1): 181-93
  • [30] Elenkov IJ, Kvetnansky R, Hashiramoto A, et al. Low- versus high-baseline epinephrine output shapes opposite innate cytokine profiles: presence of Lewis- and Fischer-like neurohormonal immune phenotypes in humans? J Immunol 2008; 181(3): 1737-45
  • [31] Zhu X, Herrera G, Ochoa JB. Immunosupression and infection after major surgery: A nutritional deficiency. Crit Care Clin 2010; 26(3): 491-500
  • [32] Braitch M, Harikrishnan S, Robins RA, et al. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand 2009; 119(4): 239-45
  • [33] Mizota T, Fujita-Kambara C, Matsuya N, et al. Effect of dietary fatty acid composition on Th1/Th2 polarization in lymphocytes. JPEN J Parenter Enteral Nutr 2009; 33(4): 390-6
  • [34] Suzuki D, Furukawa K, Kimura F, et al. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery 2010; 148(3): 573-81
  • [35] Klek S, Sierzega M, Szybinski P, et al. The immunomodulating enteral nutrition in malnourished surgical patients - a prospective, randomized, double-blind clinical trial. Clin Nutr 2011; 30(3): 282-8
  • [36] Mudge L, Isenring E, Jamieson GG. Immunonutrition in patients undergoing esophageal cancer resection. Dis Esophagus 2011; 24(3): 160-5
  • [37] 37-Buijs N, van Bokhorst-de van der Schueren MA, Langius JA, et al. Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival. Am J Clin Nutr 2010; 92(5): 1151-6
  • [38] Norian LA, Rodriguez PC, O’Mara LA, et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res 2009; 69(7): 3086-94
  • [39] Rodriguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 2008; 222: 180-91
  • [40] Cockbain AJ, Toogood GJ, Hull MA. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2012; 61(1): 135-49
  • [41] Murphy RA, Mourtzakis M, Chu QS, et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 2011; 117(8):1775-82
  • [42] Puja Dullo, Neeraj Vedi. Importance of immunonutrients. Pak J Physiol 2010; 6(1)
  • [43] Calder PC. Immunonutrition. Brit Med J 2003; 327, 117-118
  • [44] Rodriguez PC, Ernstoff MS, Hernandez C, et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69(4): 1553-60
  • [45] Thieme RD, Cutchma G, Chieferdecker ME, et al. Nutritional risk index is predictor of postoperative complications in operations of digestive system or abdominal wall? Arq Bras Cir Dig 2013; 26 (4): 286-292
  • [46] Chandrasinghe C, Dileepa S, Sumudu K, et al. Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis. BMC Clinical Pathology 2013, 13: 12
  • [47] Campos AC, Groth AK, Branco AB. Assessment and nutritional aspects of wound healing. Curr Opin Clin Nutr Metab Care. 2008; 11: 281–8
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.